Epigenetic regulation on GABRB2 isoforms expression: Developmental variations and disruptions in psychotic disorders

Schizophrenia Research

Volumn 134, Issue 2-3, 2012, Pages 260-266

  Zhao, Cunyou ^a   Wang, Feng ^a   Pun, Frank W ^a   Mei, Lingling ^a   Ren, Lihuan ^a   Yu, Zhiliang ^a   Ng, Siu Kin ^a   Chen, Jianhuan ^a   Tsang, Shui Ying ^a   Xue, Hong ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Age; Bipolar disorder; DNA methylation; Histone acetylation; MRNA expression; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BETA2; DNA METHYLTRANSFERASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2;

ADULT; AGE; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; BRAIN TISSUE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DISEASE DURATION; DNA METHYLATION; EPIGENETICS; GABRB2 GENE; GENE; GENE EXPRESSION; GENETIC REGULATION; GENOTYPE; HISTONE ACETYLATION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSYCHOSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84856292597     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.11.029     Document Type: Article

References (27)

1. Benes F.M., Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001, 25(1):1-27.
2. Chomczynski P. A reagent for single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993, 15(3):532-536.
3. Craddock N., O'Donovan M.C., Owen M.J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J. Med. Genet. 2005, 42(3):193-204.
4. Gavin D.P., Sharma R.P. Histone modifications, DNA methylation, and schizophrenia. Neurosci. Biobehav. Rev. 2010, 34(6):882-888.
5. Grayson D.R., Jia X., Chen Y., Sharma R.P., Mitchell C.P., Guidotti A., Costa E. Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(26):9341-9346.
6. Hoenicka J., Garrido E., Ponce G., Rodríguez-Jiménez R., Martínez I., Rubio G., Jiménez-Arriero M.Á., Palomo T. Sexually dimorphic interaction between the DRD1 and COMT genes in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(4):948-954.
7. Huang H.S., Akbarian S. GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS One 2007, 2(8):e809.
8. A receptor subtypes as targets for neuropsychiatric drug development. Pharmacol. Ther. 2006, 109(1-2):12-32.
9. Kringlen E. Twin studies in schizophrenia with special emphasis on concordance figures. Am. J. Med. Genet. 2000, 97(1):4-11.
10. A receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J. Neurosci. 1992, 12(11):4151-4172.
11. Lo W.S., Lau C.F., Xuan Z., Chan C.F., Feng G.Y., He L., Cao Z.C., Liu H., Luan Q.M., Xue H. Association of SNPs and haplotypes in GABAA receptor β2 gene with schizophrenia. Mol. Psychiatry 2004, 9(6):603-608.
12. Lo W.S., Harano M., Gawlik M., Yu Z., Chen J., Pun F.W., Tong K.-L., Zhao C., Ng S.-K., Tsang S.-Y., Uchimura N., Stober G., Xue H. GABRB2 association with schizophrenia: commonalities and differences between ethnic groups and clinical subtypes. Biol. Psychiatry 2007, 61(5):653-660.
13. 2 gene. PLoS One 2007, 2(5):e462.
14. Markow T.A., Wandler K. Fluctuating dermatoglyphic asymmetry and the genetics of liability to schizophrenia. Psychiatry Res. 1986, 19(4):323-328.
15. A receptor. Brain Res. Mol. Brain Res. 1995, 28(1):175-179.
16. Ng S.-K., Lo W.-S., Pun F.W., Zhao C., Yu Z., Chen J., Tong K.-L., Xu Z., Tsang S.-Y., Yang Q., Yu W., Nimgaonkar V., Stober G., Harano M., Xue H. A recombination hotspot in a schizophrenia-associated region of GABRB2. PLoS One 2010, 5(3):e9547.
17. Perlis R.H., Purcell S., Fagerness J., Kirby A., Petryshen T.L., Fan J., Sklar P. Family-based association study of lithium-related and other candidate genes in bipolar disorder. Arch. Gen. Psychiatry 2008, 65(1):53-61.
18. 2 subunit. Mol. Psychiatry 2011, 16(5):557-568.
19. Sharma R.P., Grayson D.R., Gavin D.P. Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr. Res. 2008, 98(1-3):111-117.
20. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The Stanley Foundation brain collection and Neuropathology Consortium. Schizophr. Res. 2000, 44(2):151-155.
21. Tsankova N., Renthal W., Kumar A., Nestler E.J. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 2007, 8(5):355-367.
22. A receptor gene family. Ann. N. Y. Acad. Sci. 1999, 868:645-653.
23. Yu Z., Chen J., Shi H., Stoeber G., Tsang S.-Y., Xue H. Analysis of GABRB2 association with schizophrenia in German population with DNA sequencing and one-label extension method for SNP genotyping. Clin. Biochem. 2006, 39(3):210-218.
24. A/benzodiazepine receptor alpha 1-subunit mRNA and [3H]flunitrazepam binding sites during postnatal development of the mouse cerebellum. Brain Res. Dev. Brain Res. 1991, 61(1):63-71.
25. A/benzodiazepine receptor beta 1, beta 2, and beta 3 subunit mRNAs in the developing mouse cerebellum. J. Comp. Neurol. 1992, 326(4):580-594.
26. 2 subunit with different electrophysiological properties: differential expression and genotypical correlations in schizophrenia. Mol. Psychiatry 2006, 11(12):1092-1105.
27. 2 subunit gene: relationships between novel isoforms and psychotic disorders. PLoS One 2009, 4(9):e6977.